120 related articles for article (PubMed ID: 8095238)
1. 5-HT1C/5-HT2 receptor blockade prevents 1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane-, but not stress-induced increases in brain tryptophan.
Chaouloff F; Layeillon C; Baudrie V
Eur J Pharmacol; 1993 Jan; 231(1):77-82. PubMed ID: 8095238
[TBL] [Abstract][Full Text] [Related]
2. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
Chaouloff F; Laude D; Baudrie V
Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
[TBL] [Abstract][Full Text] [Related]
3. The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior.
Klint T; Dahlgren IL; Larsson K
Eur J Pharmacol; 1992 Mar; 212(2-3):241-6. PubMed ID: 1601066
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOI.
Baudrie V; Chaouloff F
Eur J Pharmacol; 1992 Mar; 213(1):41-6. PubMed ID: 1499656
[TBL] [Abstract][Full Text] [Related]
5. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
[TBL] [Abstract][Full Text] [Related]
6. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
[TBL] [Abstract][Full Text] [Related]
7. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI.
Lawton CL; Blundell JE
Pharmacol Biochem Behav; 1993 Oct; 46(2):349-60. PubMed ID: 8265689
[TBL] [Abstract][Full Text] [Related]
8. (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex.
Edwards E; Ashby CR; Wang RY
Neuropharmacology; 1992 Jul; 31(7):615-21. PubMed ID: 1407401
[TBL] [Abstract][Full Text] [Related]
9. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
[TBL] [Abstract][Full Text] [Related]
10. Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
Aulakh CS; Hill JL; Yoney HT; Murphy DL
Psychopharmacology (Berl); 1992; 109(4):444-8. PubMed ID: 1365860
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
Berendsen HH; Broekkamp CL
Psychopharmacology (Berl); 1991; 105(2):219-24. PubMed ID: 1839064
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
Albinsson A; Palazidou E; Stephenson J; Andersson G
Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
[TBL] [Abstract][Full Text] [Related]
13. Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
Done CJ; Sharp T
Br J Pharmacol; 1992 Sep; 107(1):240-5. PubMed ID: 1422575
[TBL] [Abstract][Full Text] [Related]
14. Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations.
Bagdy G; Kalogeras KT; Szemeredi K
Eur J Pharmacol; 1992 Dec; 229(1):9-14. PubMed ID: 1473565
[TBL] [Abstract][Full Text] [Related]
15. 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats.
Schechter LE; Simansky KJ
Psychopharmacology (Berl); 1988; 94(3):342-6. PubMed ID: 3128809
[TBL] [Abstract][Full Text] [Related]
16. Central 5-hydroxytryptamine2 receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5-hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat.
Chaouloff F; Gunn SH; Young JB
J Pharmacol Exp Ther; 1992 Mar; 260(3):1008-16. PubMed ID: 1545373
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
Rittenhouse PA; Bakkum EA; Van de Kar LD
J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
[TBL] [Abstract][Full Text] [Related]
18. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats.
Anderson IK; Martin GR; Ramage AG
Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
Bagdy G; Kalogeras KT
Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
[TBL] [Abstract][Full Text] [Related]
20. Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors.
Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Hill JL; Murphy DL
Psychopharmacology (Berl); 1995 Jan; 117(2):193-9. PubMed ID: 7753967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]